The transcriptome biomarker profile, which includes the leucine zipper putative tumor suppressor 1, fibroblast growth factor receptor substrate 2, cyclin I, the EGF receptor, FGF-19, B-Raf gene, and growth regulation by estrogen in breast cancer 1, has been identified. Here, FRS2 is linked to breast carcinoma.